Jim Simons Immucell Corp Transaction History
Renaissance Technologies LLC
- $63.1 Billion
- Q3 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Immucell Corp stock. As of the latest transaction made, Renaissance Technologies LLC holds 149,489 shares of ICCC stock, worth $551,614. This represents 0.0% of its overall portfolio holdings.
Number of Shares
149,489
Previous 125,589
19.03%
Holding current value
$551,614
Previous $609,000
11.0%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding ICCC
# of Institutions
23Shares Held
1.15MCall Options Held
0Put Options Held
0-
Cresset Asset Management, LLC Chicago, IL264KShares$974,1670.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA226KShares$832,4450.0% of portfolio
-
Bleichroeder LP New York, NY102KShares$374,8810.12% of portfolio
-
Dimensional Fund Advisors LP Austin, TX72.7KShares$268,1960.0% of portfolio
-
Morgan Stanley New York, NY63.5KShares$234,3740.0% of portfolio
About IMMUCELL CORP
- Ticker ICCC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 7,746,860
- Market Cap $28.6M
- Description
- ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive ...